An Atypical Case of Extrapulmonary Presentation of SARS-Cov-2 Infection

Main Article Content

Thet Tun*
Merhej Hannun

Abstract

We present a case of a 26-year-old male who presented with diarrhoea, vomiting, chest pain and fever without respiratory symptoms including interstitial pneumonitis/pneumonia. He deteriorated with hypotension, persistently high fever and multiorgan involvement. Troponins were elevated and Electrocardiogram (ECG) showed non-specific T-wave and ST changes. Initial echocardiography showed severely reduced ejection fraction. He tested positive for a PCR nasopharyngeal swab for SARS‐CoV‐2. The patient recovered with about 10 days of only supportive care and his cardiac function returned to baseline, even though initial echocardiography had shown severely reduced left ventricular function. Although COVID-19 manifests primarily as a respiratory disease, few cases of cardiac injury without respiratory involvement have been reported. This case illustrates that COVID-19 can present atypically and affect multiorgan systems without significant respiratory system involvement.

Downloads

Download data is not yet available.

Article Details

Tun, T., & Hannun, M. (2020). An Atypical Case of Extrapulmonary Presentation of SARS-Cov-2 Infection. Journal of Cardiovascular Medicine and Cardiology, 7(4), 296–301. https://doi.org/10.17352/2455-2976.000156
Case Reports

Copyright (c) 2020 Tun T, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, et al. (2020) Management of Cardiovascular Disease Patients with Confirmed or Suspected COVID-19 in Limited Resource Settings. Link: https://bit.ly/37ALqbg

Pirzada A, Mokhtar A, Moeller A (2020) COVID-19 and Myocarditis: What Do We Know So Far?. CJC Open 2: 278-285. Link: https://bit.ly/3mBax3J

Symptoms of Coronavirus and Myocarditis – Myocarditis Foundation. (2020). Link: https://bit.ly/3oicrXr

ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic (2020). Link: https://bit.ly/2JInF8x

Tissières P, Teboul JL (2020) SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications? Ann Intensive Care 10: 98. Link: https://bit.ly/2KUjsPO

‌American College of Cardiology. (n.d.). Cardiac Sequalae in Severe COVID-19 Patients: NEJM Case Study Instructive. Link: https://bit.ly/2VxbGxA

www.jwatch.org. (n.d.). NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals. [online] Link: https://bit.ly/33DKvFP

‌Abdelnabi M, Eshak N, Saleh Y, Almaghraby A (2020) Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management. Journal - Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management. Link: https://bit.ly/37yHp7b

Talasaz AH, Kakavand H, Van Tassell B, Aghakouchakzadeh M, Sadeghipour P, et al. (2020) Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective. Cardiovascular Drugs and Therapy. Link: https://bit.ly/2I3vLs0

‌Nijjer SS, Petraco R, Sen S (2020) Optimal management of acute coronary syndromes in the era of COVID-19. Heart 106. Link: https://bit.ly/3mDsE9a

‌Delang L, Neyts J (2020) Medical treatment options for COVID-19. European Heart Journal: Acute Cardiovascular Care 9: 209-214. Link: https://bit.ly/3qnvZLV